Free Trial

Vertex Pharmaceuticals (VRTX) SEC Filings & 10K Form

Vertex Pharmaceuticals logo
$457.03 +4.87 (+1.08%)
Closing price 04:00 PM Eastern
Extended Trading
$457.00 -0.03 (-0.01%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vertex Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/19/2025
3:24 PM
Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
9:36 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2025
10:32 AM
Capital Research Global Investors (Filed by)
Vertex Pharmaceuticals (Subject)
Form SCHEDULE 13G
05/05/2025
3:52 PM
MCKENZIE DIANA (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:55 PM
SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:57 PM
Schneider Jennifer (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:14 PM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:16 PM
CARNEY LLOYD (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:19 PM
Garber Alan M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:47 AM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2025
3:07 PM
SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
3:08 PM
Upadhyay Suketu (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
10:10 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
3:11 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
12:58 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
12:02 PM
Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
11:42 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
3:08 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:08 PM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
12:39 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:17 PM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
3:43 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:46 PM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:48 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:31 PM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:36 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
10:20 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
9:18 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
9:14 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
3:06 PM
Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:07 PM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:09 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:11 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
10:38 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
9:59 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
10:13 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
3:07 PM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
2:45 PM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:30 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:31 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:33 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
02/19/2025
3:21 PM
Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
10:29 AM
Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
10:34 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
3:17 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:14 PM
Vertex Pharmaceuticals (Filer)
Form S-3ASR
02/13/2025
3:53 PM
Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/12/2025
3:46 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:48 PM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:50 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:52 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:26 PM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:21 PM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:24 PM
Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:34 AM
FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/11/2025
10:57 AM
Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
10:05 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
8:49 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2025
3:43 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:45 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:37 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:38 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:32 PM
Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:35 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:07 PM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
2:51 PM
Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
9:31 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
3:15 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
1:58 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
3:11 PM
Vertex Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2024
3:12 PM
SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:12 PM
Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
9:04 AM
Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:47 PM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:23 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
3:08 PM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
10:47 AM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:52 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:17 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
2:34 PM
SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
2:25 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:06 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:05 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
11:27 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
12:16 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
9:27 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRTX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners